News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
24,598 Results
Type
Article (457)
Company Profile (3)
Press Release (24138)
Section
Business (6979)
Career Advice (17)
Deals (1449)
Drug Delivery (1)
Drug Development (3447)
Employer Resources (7)
FDA (297)
Job Trends (413)
News (11763)
Policy (624)
Tag
2024 Pharm Country Digital (1)
Academia (27)
Allergies (4)
Alliances (1016)
ALS (5)
Alzheimer's disease (88)
Antibody-drug conjugate (ADC) (1)
Approvals (296)
Artificial intelligence (8)
Bankruptcy (5)
Best Places to Work (310)
Biotechnology (4)
Bladder cancer (1)
Brain cancer (2)
Breast cancer (14)
Cancer (92)
Cardiovascular disease (4)
Career advice (16)
Career pathing (1)
CAR-T (7)
Cell therapy (23)
Cervical cancer (2)
Clinical research (2883)
Collaboration (27)
Compensation (48)
COVID-19 (47)
C-suite (10)
Cystic fibrosis (5)
Data (149)
Depression (1)
Diabetes (22)
Diagnostics (260)
Diversity, equity & inclusion (2)
Drug discovery (4)
Earnings (3968)
Employer branding (3)
Employer resources (7)
Events (6734)
Executive appointments (45)
FDA (349)
Featured Employer (1)
Frontotemporal dementia (1)
Funding (27)
Gene editing (2)
Generative AI (1)
Gene therapy (8)
GLP-1 (7)
Government (44)
Guidances (3)
Healthcare (912)
IgA nephropathy (1)
Immunology and inflammation (4)
Infectious disease (50)
Inflammatory bowel disease (6)
Influenza (3)
Interviews (2)
IPO (1083)
Job creations (89)
Job search strategy (16)
Layoffs (5)
Leadership (1)
Legal (109)
Liver cancer (2)
Lung cancer (7)
Lymphoma (5)
Management (1)
Manufacturing (11)
MASH (8)
Medical device (559)
Medtech (560)
Mergers & acquisitions (439)
Metabolic disorders (42)
Multiple sclerosis (3)
NASH (1)
Neurodegenerative disease (2)
Neuroscience (115)
NextGen: Class of 2025 (106)
Non-profit (38)
Northern California (243)
Now hiring (1)
Obesity (11)
Opinion (1)
Ovarian cancer (2)
Pain (4)
Pancreatic cancer (7)
Parkinson's disease (9)
Patents (8)
Patient recruitment (5)
Peanut (1)
People (2077)
Phase I (970)
Phase II (1538)
Phase III (793)
Pipeline (98)
Postmarket research (11)
Preclinical (383)
Press Release (22)
Prostate cancer (6)
Radiopharmaceuticals (9)
Rare diseases (15)
Real estate (126)
Recruiting (3)
Regulatory (541)
Research institute (24)
Resumes & cover letters (1)
Schizophrenia (8)
Series A (3)
Series B (1)
Sickle cell disease (5)
Southern California (256)
Spinal muscular atrophy (2)
Startups (117)
Supply chain (2)
United States (1805)
Vaccines (3)
Webinars (2)
Weight loss (1)
Date
Today (4)
Last 7 days (51)
Last 30 days (192)
Last 365 days (2521)
2025 (532)
2024 (2732)
2023 (3329)
2022 (3984)
2021 (4129)
2020 (3138)
2019 (1285)
2018 (732)
2017 (855)
2016 (439)
2015 (660)
2014 (502)
2013 (335)
2012 (264)
2011 (275)
2010 (258)
Location
Africa (13)
Alabama (1)
Arizona (1)
Asia (2326)
Australia (389)
California (607)
Canada (46)
China (6)
Colorado (19)
Connecticut (2)
Europe (3302)
Florida (83)
Georgia (3)
Illinois (13)
India (1)
Indiana (19)
Iowa (1)
Japan (2)
Maryland (47)
Massachusetts (359)
Michigan (11)
Minnesota (14)
Missouri (1)
Nevada (16)
New Jersey (191)
New York (176)
North Carolina (106)
Northern California (243)
Ohio (2)
Oregon (2)
Pennsylvania (111)
Puerto Rico (1)
South America (14)
Southern California (256)
Texas (40)
Utah (16)
Washington State (11)
Wisconsin (1)
24,598 Results for "alcyone lifesciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Alcyone Therapeutics Announces Appointment of Dr. Norbert Riedel as Chairman of the Board and Dr. Kathrin Meyer as Chief Scientific Officer and Head of Research & Development
Alcyone Therapeutics announces appointments of Norbert Riedel, Ph.D., a skilled and experienced biopharmaceutical executive, as the Chairman of its Board of Directors, and Kathrin Meyer, Ph.D., a leader in development and clinical translation of genetic therapies for the central nervous system, as Alcyone’s new Chief Scientific Officer and Head of R&D.
May 8, 2024
·
4 min read
Genetown
Alcyone Therapeutics Announces First Patient Implanted in PIERRE IDE Clinical Study of the ThecaFlex DRx™ System for Administration of SPINRAZA® (nusinersen)
Alcyone Therapeutics Inc. announced the first patient implanted in the PIERRE pivotal study to evaluate the safety and performance of the ThecaFlex DRx System.
January 3, 2024
·
8 min read
Press Releases
Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026
March 28, 2025
·
4 min read
Press Releases
Edwards Lifesciences Reports Fourth Quarter Results
February 12, 2025
·
19 min read
Press Releases
Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results
March 18, 2025
·
24 min read
Press Releases
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
March 14, 2025
·
1 min read
Press Releases
Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01
March 17, 2025
·
8 min read
Press Releases
Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio
February 24, 2025
·
4 min read
Press Releases
Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland
January 27, 2025
·
6 min read
FDA
Alcyone Therapeutics Receives FDA IDE Approval to Initiate Clinical Study of the ThecaFlex DRxTM System for Administration of SPINRAZA® (nusinersen)
Alcyone Therapeutics Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) to initiate a pivotal trial of Alcyone’s ThecaFlex DRx System (ThecaFlex).
June 27, 2023
·
7 min read
1 of 2,460
Next
